• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ROR1 在人乳腺癌中表达,并与增强的肿瘤细胞生长相关。

ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.

机构信息

Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, United States of America.

出版信息

PLoS One. 2012;7(3):e31127. doi: 10.1371/journal.pone.0031127. Epub 2012 Mar 5.

DOI:10.1371/journal.pone.0031127
PMID:22403610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3293865/
Abstract

Receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) is expressed during embryogenesis and by certain leukemias, but not by normal adult tissues. Here we show that the neoplastic cells of many human breast cancers express the ROR1 protein and high-level expression of ROR1 in breast adenocarcinoma was associated with aggressive disease. Silencing expression of ROR1 in human breast cancer cell lines found to express this protein impaired their growth in vitro and also in immune-deficient mice. We found that ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth. Wnt5a, a ligand of ROR1, could induce ROR1-dependent signaling and enhance cell growth. This study demonstrates that ROR1 is expressed in human breast cancers and has biological and clinical significance, indicating that it may be a potential target for breast cancer therapy.

摘要

受体酪氨酸激酶样孤儿受体 1(ROR1)在胚胎发生过程中表达,并存在于某些白血病中,但不存在于正常成人组织中。在这里,我们表明许多人类乳腺癌中的肿瘤细胞表达 ROR1 蛋白,并且乳腺癌腺癌中 ROR1 的高表达与侵袭性疾病相关。沉默在表达这种蛋白的人类乳腺癌细胞系中表达 ROR1 会损害其体外生长,并且在免疫缺陷小鼠中也会损害其生长。我们发现 ROR1 可以与酪蛋白激酶 1 ɛ(CK1ε)相互作用,以激活磷酸肌醇 3-激酶介导的 AKT 磷酸化和 cAMP 反应元件结合蛋白(CREB),从而与增强的肿瘤细胞生长相关。ROR1 的配体 Wnt5a 可以诱导 ROR1 依赖性信号传导并增强细胞生长。这项研究表明 ROR1 在人类乳腺癌中表达,并具有生物学和临床意义,表明它可能是乳腺癌治疗的潜在靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/d44505748ce6/pone.0031127.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/4c2d4710c69b/pone.0031127.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/36e44df8b3c2/pone.0031127.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/8e0364cf7999/pone.0031127.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/1b6c9e3fefb3/pone.0031127.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/69888743d9fb/pone.0031127.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/d44505748ce6/pone.0031127.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/4c2d4710c69b/pone.0031127.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/36e44df8b3c2/pone.0031127.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/8e0364cf7999/pone.0031127.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/1b6c9e3fefb3/pone.0031127.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/69888743d9fb/pone.0031127.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9371/3293865/d44505748ce6/pone.0031127.g006.jpg

相似文献

1
ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.ROR1 在人乳腺癌中表达,并与增强的肿瘤细胞生长相关。
PLoS One. 2012;7(3):e31127. doi: 10.1371/journal.pone.0031127. Epub 2012 Mar 5.
2
The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.癌胚胚胎抗原 ROR1 在多种人类癌症中表达。
Am J Pathol. 2012 Dec;181(6):1903-10. doi: 10.1016/j.ajpath.2012.08.024. Epub 2012 Oct 4.
3
ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.ROR1通过PI3K/Akt信号通路调控N-钙黏蛋白的表达,从而促进黑色素瘤细胞的生长和迁移。
Mol Carcinog. 2016 Nov;55(11):1772-1785. doi: 10.1002/mc.22426. Epub 2015 Oct 28.
4
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.Wnt5a诱导ROR1/ROR2异源寡聚化以增强白血病的趋化性和增殖。
J Clin Invest. 2016 Feb;126(2):585-98. doi: 10.1172/JCI83535.
5
Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.受体酪氨酸激酶ROR1沉默通过PI3K/AKT/mTOR信号通路抑制肺腺癌肿瘤细胞增殖
PLoS One. 2015 May 15;10(5):e0127092. doi: 10.1371/journal.pone.0127092. eCollection 2015.
6
Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.靶向 ROR1 抑制上皮间质转化和转移。
Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832.
7
Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.受体酪氨酸激酶样孤儿受体 1 在子痫前期胎盘组织中的下调通过 PI3K/AKT/mTOR 通路抑制人滋养细胞增殖、迁移和侵袭。
Placenta. 2019 Jul;82:17-24. doi: 10.1016/j.placenta.2019.05.002. Epub 2019 May 12.
8
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.卵巢癌干细胞表达ROR1,它可成为抗癌干细胞治疗的靶点。
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17266-71. doi: 10.1073/pnas.1419599111. Epub 2014 Nov 19.
9
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.通过输注自体腺病毒载体-CD154转导的白血病B细胞诱导产生的抗血清将ROR1鉴定为一种癌胚抗原和Wnt5a的受体。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3047-52. doi: 10.1073/pnas.0712148105. Epub 2008 Feb 19.
10
The signaling pathways activated by ROR1 in cancer.ROR1 在癌症中激活的信号通路。
Cell Signal. 2023 Apr;104:110588. doi: 10.1016/j.cellsig.2023.110588. Epub 2023 Jan 5.

引用本文的文献

1
Trispecific SEED antibodies engineered for neutrophil-mediated cell killing.经工程改造用于中性粒细胞介导的细胞杀伤的三特异性SEED抗体。
MAbs. 2025 Dec;17(1):2532851. doi: 10.1080/19420862.2025.2532851. Epub 2025 Jul 15.
2
Arylsulfatase B induces melanoma apoptosis by the ubiquitin ligase COP1.芳基硫酸酯酶B通过泛素连接酶COP1诱导黑色素瘤细胞凋亡。
J Biol Chem. 2025 Jun 23;301(8):110402. doi: 10.1016/j.jbc.2025.110402.
3
In Silico Identification of 2,4-Diaminopyrimidine-Based Compounds as Potential CK1ε Inhibitors.基于2,4-二氨基嘧啶的化合物作为潜在CK1ε抑制剂的计算机模拟鉴定

本文引用的文献

1
Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.Ror1 是一种伪激酶,对 Met 驱动的肿瘤发生至关重要。
Cancer Res. 2011 Apr 15;71(8):3132-41. doi: 10.1158/0008-5472.CAN-10-2662. Epub 2011 Apr 12.
2
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.用 siRNA 沉默 ROR1 和 FMOD 可导致 CLL 细胞凋亡。
Br J Haematol. 2010 Nov;151(4):327-35. doi: 10.1111/j.1365-2141.2010.08362.x. Epub 2010 Aug 31.
3
Targeting CREB for cancer therapy: friend or foe.针对 CREB 的癌症治疗策略:是敌是友。
Pharmaceuticals (Basel). 2025 May 17;18(5):741. doi: 10.3390/ph18050741.
4
Uncovering a Novel Role of ROR1 in the Epigenetic Regulation of Tumor Suppressor Gene CREB3L1 in Triple-Negative Breast Cancer Cells.揭示ROR1在三阴性乳腺癌细胞中肿瘤抑制基因CREB3L1表观遗传调控中的新作用。
Biomolecules. 2025 May 16;15(5):734. doi: 10.3390/biom15050734.
5
Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors.乳腺癌的免疫治疗:超越免疫检查点抑制剂
Int J Mol Sci. 2025 Apr 21;26(8):3920. doi: 10.3390/ijms26083920.
6
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization.新型对苯二胺基衍生物作为受体酪氨酸激酶样孤儿受体1(ROR1)抑制剂:体外初步表征
ChemMedChem. 2025 Jul 18;20(14):e202500247. doi: 10.1002/cmdc.202500247. Epub 2025 Jun 1.
7
Expression and treatment of ROR1+ cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia.双特异性T细胞衔接器对小儿急性淋巴细胞白血病中ROR1+细胞的表达及治疗作用
Blood Adv. 2025 Jul 8;9(13):3190-3201. doi: 10.1182/bloodadvances.2024013814.
8
A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.一种新型的靶向ROR1的抗体-PROTAC偶联物可促进BRD4降解用于实体瘤治疗。
Theranostics. 2025 Jan 1;15(4):1238-1254. doi: 10.7150/thno.102531. eCollection 2025.
9
Therapeutic advances in the targeting of ROR1 in hematological cancers.血液系统恶性肿瘤中靶向ROR1的治疗进展。
Cell Death Discov. 2024 Nov 17;10(1):471. doi: 10.1038/s41420-024-02239-1.
10
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.ROR1特异性嵌合抗原受体T细胞在晚期造血和上皮恶性肿瘤中的I期研究。
Clin Cancer Res. 2025 Feb 3;31(3):503-514. doi: 10.1158/1078-0432.CCR-24-2172.
Curr Cancer Drug Targets. 2010 Jun;10(4):384-91. doi: 10.2174/156800910791208535.
4
RNAi screen for rapid therapeutic target identification in leukemia patients.用于白血病患者快速治疗靶点鉴定的RNA干扰筛选
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8695-700. doi: 10.1073/pnas.0903233106. Epub 2009 May 11.
5
CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.CREB在癌症病理生理学中的作用:对癌症治疗中靶向转录因子的启示
Clin Cancer Res. 2009 Apr 15;15(8):2583-7. doi: 10.1158/1078-0432.CCR-08-1137. Epub 2009 Apr 7.
6
cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation.环磷酸腺苷反应元件结合蛋白在人类卵巢腺癌中高表达,并调节卵巢肿瘤细胞的增殖。
Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1248-57. doi: 10.1111/j.1525-1438.2007.01177.x. Epub 2008 Jun 11.
7
Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.Ror1是一种细胞表面受体酪氨酸激酶,在慢性淋巴细胞白血病中表达,可能成为一个潜在的治疗靶点。
Int J Cancer. 2008 Sep 1;123(5):1190-5. doi: 10.1002/ijc.23587.
8
Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest.抑制酪蛋白激酶1-ε可诱导癌细胞选择性、依赖周期蛋白2的生长停滞。
Genome Biol. 2008;9(6):R92. doi: 10.1186/gb-2008-9-6-r92. Epub 2008 Jun 2.
9
Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.孤儿受体酪氨酸激酶Ror1作为一种假定的肿瘤相关抗原在伊朗急性淋巴细胞白血病患者中的过表达
Tumour Biol. 2007;28(6):318-26. doi: 10.1159/000121405. Epub 2008 Mar 20.
10
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.通过输注自体腺病毒载体-CD154转导的白血病B细胞诱导产生的抗血清将ROR1鉴定为一种癌胚抗原和Wnt5a的受体。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3047-52. doi: 10.1073/pnas.0712148105. Epub 2008 Feb 19.